Results 121 to 130 of about 7,418 (172)

Leishmaniasis Transmission Risk at the Forest-Peridomestic Interface in an Area of Southern Sinaloa, Mexico: Entomological, Molecular, and Climatic Evidence. [PDF]

J Parasitol Res
Tostado JJR, Ureta HC, Avendaño JIT, Moreno JMZ, Higareda CER, Guevara LIP, Medina AIA, Montoya EHT.   +7 more
europepmc   +1 more source

Ferroptosis and Nrf-2 signaling: a redox tug of war in leishmaniasis pathogenesis and host directed therapy. [PDF]

Redox Biol
Dar MJ, Huston RH, Purayil N, Cronin AI, Gondal SA, Nakhasi HL, Brito R, Gannavaram S, Satoskar AR.   +8 more
europepmc   +1 more source

[A study of experimental cutaneous leishmaniasis in white mice].

Meditsinskaia parazitologiia i parazitarnye bolezni, 1998
openaire   +1 more source

Leishmanicidal Action of the Peptides 19-4LF, 19-2.5 and 19-2.5LF Topically Administered on Cutaneous Lesions Caused by <i>Leishmania major</i>. [PDF]

Pharmaceutics
El-Dirany R, Ginatta P, Fernández-Rubio C, Burguete-Mikeo A, Larrea E, Martinez-de-Tejada G, Nguewa PA.   +6 more
europepmc   +1 more source

First molecular detection of <i>Leishmania infantum</i> in a domestic cat from Costa Rica. [PDF]

JFMS Open Rep
Sánchez-Bermúdez JF, Pacheco E, García R, Achí L, Zuniga-Moya MJ, Bonilla MC, Dolz G.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Efficacy of topical Miltefosine formulations in an experimental model of cutaneous leishmaniasis

Drug Delivery and Translational Research, 2021
Cutaneous leishmaniasis (CL) is a neglected tropical disease endemic in ~ 90 countries, with an increasing incidence. Presently available pharmacotherapy implies the systemic administration of moderately/very toxic drugs. Miltefosine (Milt) is the only FDA-approved drug to treat CL via the oral route (Impavido®). It produces side effects; in particular,
Maria Florencia Peralta, Dolores C Carrer   +1 more
exaly   +4 more sources

Experimental cutaneous leishmaniasis

Acta Tropica, 1997
Silveira Ft, Jeffrey Jon Shaw, Ralph Lainson   +2 more
exaly   +2 more sources

Immunobiology of experimental cutaneous leishmaniasis

Parasitology Today, 1995
The study of the murine model of infection with Leishmania major is providing important insights into the understanding of the complex interactions between the host and intracellular pathogens. Using this model system, basic research is actively leading to the identification of host factors promoting or circumventing the development of immunity to L ...
G, Milon, G, Del Giudice, J A, Louis
openaire   +2 more sources

Natural Killer Activity in Experimental Cutaneous Leishmaniasis

International Archives of Allergy and Applied Immunology, 2009
Studies were performed to determine the role of natural killer (NK) cell cytotoxicity in experimental cutaneous leishmaniasis. Analysis of a possible correlation between in vitro NK cell activity and in vivo susceptibility to Leishmania mexicana infection showed that there is no relationship between the degree of NK reactivity to YAC-1 lymphoma cells ...
F, Merino, I, Cruz
openaire   +2 more sources